Nasal polyps can be a persistent issue for individuals suffering from chronic sinusitis, allergies, or fungal infections, ...
Chronic rhinosinusitis with nasal polyps presents a substantial clinical burden, affecting nasal airflow, olfactory function, and quality of life. Epithelial barrier dysfunction and type 2 ...
Phase 3 trials showed significant improvements in nasal polyp size and obstruction. Markets are swinging wildly, but for Matt Maley, it's just another opportunity to trade. His clear, simple trade ...
(RTTNews) - The Phase III WAYPOINT trial results revealed that AstraZeneca (AZN.L, AZN) and Amgen's (AMGN) TEZSPIRE (tezepelumab-ekko) significantly decreased nasal polyp severity, reduced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results